BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• 

  IN PARTNERSHIP WITH VIVA BIOTECH

  Building the Next Generation of Biologics: Inside the Future of Protein Engineering

  As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new bottleneck: engineering and producing molecules whose complexity challenges conventional workflows.

  December 1, 2025

   · 

  9 min read

   · 

  BioSpace Insights
• Press Releases

  At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care

  December 1, 2025

   · 

  4 min read
• Press Releases

  Samsung Bioepis Announces Launch of Denosumab Biosimilars, OBODENCE™ and XBRYK™, in Europe

  December 1, 2025

   · 

  5 min read
• Press Releases

  Ipsen mourns the passing of Henri Beaufour, a founding family Board member

  December 1, 2025

   · 

  6 min read
• Press Releases

  Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

  December 1, 2025

   · 

  4 min read
• Press Releases

  Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025

  December 1, 2025

   · 

  3 min read
• Press Releases

  MedMira Reports FY2025 Fourth Quarter and Year End Financial Results

  December 1, 2025

   · 

  5 min read
• Press Releases

  Advanced CEM tracking enables more comprehensive breast cancer detection and care coordination

  December 1, 2025

   · 

  2 min read
• Press Releases

  Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program

  December 1, 2025

   · 

  5 min read
• Press Releases

  Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock

  December 1, 2025

   · 

  5 min read